Suresh Mahalingam Selected Research

Alphavirus Infections

10/2023	FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
1/2019	Inhibition of Interleukin-1β Signaling by Anakinra Demonstrates a Critical Role of Bone Loss in Experimental Arthritogenic Alphavirus Infections.
8/2015	Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease.
2/2015	Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation.
10/2013	Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suresh Mahalingam Research Topics

Disease

27	Infections 11/2023 - 02/2006
17	Arthritis (Polyarthritis) 10/2023 - 01/2007
13	Myositis (Idiopathic Inflammatory Myopathies) 10/2023 - 05/2007
10	Inflammation (Inflammations) 12/2022 - 10/2006
7	Virus Diseases (Viral Diseases) 06/2019 - 07/2008
5	Alphavirus Infections 10/2023 - 10/2013
5	Rheumatoid Arthritis 01/2022 - 07/2011
4	Chikungunya Fever 01/2017 - 11/2013
3	COVID-19 01/2023 - 01/2021
3	Ross River Virus Infection 01/2022 - 11/2014
3	Joint Diseases (Joint Disease) 01/2022 - 01/2017
3	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 07/2011
3	Necrosis 10/2018 - 12/2009
2	Pneumonia (Pneumonitis) 01/2023 - 10/2018
2	Chronic Disease (Chronic Diseases) 01/2022 - 01/2017
2	Viremia 01/2020 - 01/2019
2	Neoplasms (Cancer) 10/2018 - 03/2013
2	Human Influenza (Influenza) 03/2017 - 01/2016
2	Disease Progression 01/2012 - 02/2011
2	Rheumatic Diseases (Rheumatism) 02/2011 - 08/2009
2	Asthma (Bronchial Asthma) 07/2008 - 10/2006
1	Mpox (monkeypox) 11/2023
1	Psoriatic Arthritis 01/2022
1	Severe Dengue 01/2021
1	Weight Loss (Weight Reduction) 01/2019
1	Flaviviridae Infections 10/2018
1	Peritonitis 10/2018
1	Fever (Fevers) 12/2017
1	Zika Virus Infection 11/2017
1	Arthralgia (Joint Pain) 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Cystitis 08/2015
1	Lung Diseases (Lung Disease) 02/2015
1	Acute Disease 02/2015

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2007
10	CytokinesIBA 10/2023 - 05/2010
6	VaccinesIBA 11/2023 - 02/2006
6	Complement System Proteins (Complement)IBA 01/2023 - 05/2007
6	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2009
6	InterferonsIBA 01/2022 - 12/2009
5	bindaritIBA 03/2017 - 08/2009
4	ChemokinesIBA 10/2023 - 05/2010
4	Polysaccharides (Glycans)IBA 01/2023 - 08/2015
4	Interferon Type IIBA 12/2017 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2010
3	Monocyte Chemoattractant ProteinsIBA 12/2015 - 08/2009
2	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2023 - 08/2015
2	Interleukin-13IBA 01/2023 - 10/2006
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2022 - 10/2010
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 10/2017 - 07/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011 - 02/2011
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2011 - 12/2009
2	EpitopesIBA 05/2010 - 02/2006
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 11/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2023
1	Retinaldehyde (Retinal)IBA 12/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	interleukin-21 (interleukin 21)IBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	Immunoglobulin IsotypesIBA 01/2022
1	AntibodiesIBA 01/2022
1	Complement Factor H (Factor H)IBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Complement Factor B (Factor B)IBA 01/2021
1	Liposomes (Liposome)IBA 01/2020
1	Inosine Monophosphate (IMP)IBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 06/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 10/2018
1	MethyltransferasesIBA 10/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2018
1	LipopolysaccharidesIBA 10/2018
1	CarrageenanIBA 10/2018
1	AntigensIBA 10/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	LigandsIBA 10/2017
1	InflammasomesIBA 10/2017
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2017
1	Interleukin-18 (Interleukin 18)IBA 10/2017
1	Interleukin-8 (Interleukin 8)IBA 03/2017
1	Chemokine CCL5IBA 01/2017
1	Granzymes (Granzyme)IBA 01/2017
1	Explosive Agents (Explosives)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Collectins (Collectin)IBA 12/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2015
1	Fc Receptors (Fc Receptor)IBA 11/2015
1	Proteoglycans (Proteoglycan)IBA 08/2015
1	GlycosaminoglycansIBA 08/2015
1	Interleukin-5 (Interleukin 5)IBA 02/2015
1	PTX3 proteinIBA 02/2015

Therapy/Procedure

8	Therapeutics 11/2023 - 02/2011